From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

At what point does Daddy Pig’s compliance officer put a stop to the Advanced Oncotherapy farce?

By Tom Winnifrith, the Sheriff of AIM | Monday 7 November 2022

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

I do not believe that Advanced Oncotherapy (AVO) will ever generate a cent of positive free cashflow as the demand for the proton therapy services it will offer at some point in 2023 is, in my view, already fully catered for with existing capacity. Others, notably a fund management firm run by a chap who looks remarkably like Daddy Pig, father of Peppa, disagree but what we might agree on its that, until late 2023, there is no doubt that Advanced will continue to guzzle cash. Which makes the next bailout placing only a matter of time.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

That Was the Week that Was



Iconic Labs – its alive!

Wednesday »


Tom Winnifrith Bearcast: Family tales



Shanta Gold – a recovery BUY!



Oscillate RTO – madness



Surely Moonpig is a short at 171p?



Video: The Road to an Energy Crisis



Beyond Meat is Beyond Redemption.

Friday »


Tom Winnifrith bearcast: Madness!



The Andrew Bell defence at Red Rock